The choice of catecholamines in septic shock: more and more good arguments to strengthen the known position, but don't lose the faith!
The choice of catecholamines for hemodynamic stabilisation in septic shock patients has been an ongoing debate for several years. Several studies have investigated the regional effects in septic patients. Because of an often very small sample size, because of inconsistent results and because of methodical problems in the monitoring techniques used in these studies, however, it is not possible to provide clear recommendations concerning the use of catecholamines in sepsis. Prospective and adequate-sized studies are necessary because outcome data are completely lacking.
Department of Anesthesiology, Intensive Care Medicine and Pain Management, HELIOS Klinikum Erfurt GmbH, Erfurt, Germany. ameier-hellmann@erfurt.helios-kliniken.de
Andreas
A
Meier-Hellmann
D002395:Catecholamines / Q000627:therapeutic use*; D003657:Decision Making; D006801:Humans; D012772:Shock, Septic / Q000188:drug therapy* / Q000453:epidemiology
D002395:Catecholamines